US drug firm Pfizer seeks to buy UK company AstraZenecaBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g2986 (Published 28 April 2014) Cite this as: BMJ 2014;348:g2986
- Andrew Jack
- 1Financial Times
Pfizer, the US pharmaceutical giant whose drugs include atorvastatin (Lipitor) and sildenafil (Viagra), is seeking to buy the UK drug firm AstraZeneca for £52bn (€63bn; $90bn), which would be one of the largest acquisitions in the drug sector in recent years.
The bid at £46.61 a share would signal the biggest foreign takeover of a UK based group. It follows initial approaches in January to AstraZeneca, which continues …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial